FR3087338B1 - Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique - Google Patents

Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique Download PDF

Info

Publication number
FR3087338B1
FR3087338B1 FR1859721A FR1859721A FR3087338B1 FR 3087338 B1 FR3087338 B1 FR 3087338B1 FR 1859721 A FR1859721 A FR 1859721A FR 1859721 A FR1859721 A FR 1859721A FR 3087338 B1 FR3087338 B1 FR 3087338B1
Authority
FR
France
Prior art keywords
prevention
post
treatment
algae extract
traumatic immunosuppression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1859721A
Other languages
English (en)
French (fr)
Other versions
FR3087338A1 (fr
Inventor
Karim Asehnoune
Cedric Jacqueline
Marwan Bouras
Antoine Roquilly
Pi Nyvall-Collen
Herve Demais
Herve Balusson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amadeite SAS
Original Assignee
Amadeite SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1859721A priority Critical patent/FR3087338B1/fr
Application filed by Amadeite SAS filed Critical Amadeite SAS
Priority to AU2019364677A priority patent/AU2019364677B2/en
Priority to JP2021546474A priority patent/JP7614105B2/ja
Priority to EP24213375.9A priority patent/EP4483961A3/fr
Priority to PCT/EP2019/078757 priority patent/WO2020083931A1/fr
Priority to CA3116952A priority patent/CA3116952A1/fr
Priority to BR112021007506-2A priority patent/BR112021007506B1/pt
Priority to CN201980069992.4A priority patent/CN113347984A/zh
Priority to KR1020217012097A priority patent/KR102922546B1/ko
Priority to US17/286,999 priority patent/US12377126B2/en
Priority to IL282511A priority patent/IL282511B1/en
Priority to EP19801216.3A priority patent/EP3870198B1/fr
Publication of FR3087338A1 publication Critical patent/FR3087338A1/fr
Application granted granted Critical
Publication of FR3087338B1 publication Critical patent/FR3087338B1/fr
Priority to AU2025200105A priority patent/AU2025200105A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR1859721A 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique Active FR3087338B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR1859721A FR3087338B1 (fr) 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
IL282511A IL282511B1 (en) 2018-10-22 2019-10-22 Algae extract for use in the treatment or prevention of post-traumatic immunosuppression
EP24213375.9A EP4483961A3 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
PCT/EP2019/078757 WO2020083931A1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
CA3116952A CA3116952A1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
BR112021007506-2A BR112021007506B1 (pt) 2018-10-22 2019-10-22 Uso de um extrato de algas verdes do tipo ulva
AU2019364677A AU2019364677B2 (en) 2018-10-22 2019-10-22 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
KR1020217012097A KR102922546B1 (ko) 2018-10-22 2019-10-22 외상 후 면역 억제의 치료 또는 예방에 사용하기 위한 조류 추출물
US17/286,999 US12377126B2 (en) 2018-10-22 2019-10-22 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
JP2021546474A JP7614105B2 (ja) 2018-10-22 2019-10-22 外傷後免疫抑制の治療又は予防への使用のための藻類抽出物
EP19801216.3A EP3870198B1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
CN201980069992.4A CN113347984A (zh) 2018-10-22 2019-10-22 用于治疗或预防创伤后免疫抑制的藻类提取物
AU2025200105A AU2025200105A1 (en) 2018-10-22 2025-01-08 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1859721A FR3087338B1 (fr) 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Publications (2)

Publication Number Publication Date
FR3087338A1 FR3087338A1 (fr) 2020-04-24
FR3087338B1 true FR3087338B1 (fr) 2020-10-09

Family

ID=65494363

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1859721A Active FR3087338B1 (fr) 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Country Status (10)

Country Link
US (1) US12377126B2 (https=)
EP (2) EP3870198B1 (https=)
JP (1) JP7614105B2 (https=)
KR (1) KR102922546B1 (https=)
CN (1) CN113347984A (https=)
AU (2) AU2019364677B2 (https=)
CA (1) CA3116952A1 (https=)
FR (1) FR3087338B1 (https=)
IL (1) IL282511B1 (https=)
WO (1) WO2020083931A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114376233A (zh) * 2022-03-23 2022-04-22 青岛海大生物集团股份有限公司 一种具有增强免疫功能的浒苔多糖保健食品及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132101B2 (en) 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
NZ542791A (en) 2003-04-08 2008-04-30 Biotempt Bv Compositions for mucosal and oral administration comprising HCG fragments
RU2417093C2 (ru) 2005-06-24 2011-04-27 Дезерт Лейк Текнолоджиз Очищенный компонент цианобактерий и способ применения
ATE514950T1 (de) 2007-09-07 2011-07-15 Univ Zuerich Verfahren zur untersuchung von sepsis bei menschen
KR101102829B1 (ko) * 2008-09-12 2012-01-05 재단법인 제주테크노파크 구멍갈파래 추출물과 그것의 항염증제로서의 용도
US9370537B2 (en) * 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
FR2954703B1 (fr) * 2009-12-28 2013-12-13 Chu Nantes Agonistes des recepteurs tlr 4 et 9 pour prevenir les complications septiques de l'immunodepression post-traumatique chez les patients hospitalises pour traumatismes severes
US20130102662A1 (en) * 2011-06-09 2013-04-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression
FR2999084B1 (fr) * 2012-12-11 2015-03-13 Amadeite Extrait d'algues comprenant en particulier des polysaccharides polyanioniques sulfates et non sulfates et ses applications
FR3013223B1 (fr) * 2013-11-18 2016-09-02 Amadeite Extrait d'algues pour son utilisation en tant qu'agent anti-bacterien
FR3013222B1 (fr) * 2013-11-18 2016-09-30 Amadeite Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur

Also Published As

Publication number Publication date
US20210386808A1 (en) 2021-12-16
US12377126B2 (en) 2025-08-05
AU2019364677A1 (en) 2021-05-20
KR102922546B1 (ko) 2026-02-04
AU2025200105A1 (en) 2025-01-23
BR112021007506A2 (pt) 2021-07-27
IL282511A (en) 2021-06-30
JP2022508900A (ja) 2022-01-19
WO2020083931A1 (fr) 2020-04-30
EP4483961A3 (fr) 2025-03-19
EP4483961A2 (fr) 2025-01-01
EP3870198C0 (fr) 2024-11-20
EP3870198A1 (fr) 2021-09-01
JP7614105B2 (ja) 2025-01-15
KR20210114921A (ko) 2021-09-24
IL282511B1 (en) 2026-02-01
EP3870198B1 (fr) 2024-11-20
CA3116952A1 (fr) 2020-04-30
FR3087338A1 (fr) 2020-04-24
AU2019364677B2 (en) 2024-10-10
CN113347984A (zh) 2021-09-03

Similar Documents

Publication Publication Date Title
MA42560B1 (fr) Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
MA42278A (fr) Compositions comprenant une souches bactérienne de blautia hydrogenotrophica pour l'utilisation pour le traitement d'infections bactériennes du tractus gastro-intestinal
MA53937A (fr) Compositions comprenant des souches bactériennes
PH12021550106A1 (en) Highly purified fucans for the treatment of fibrous adhesions
MA44322A (fr) Compositions comprenant des souches bactériennes
MY203083A (en) Imidazopyrazine inhibitors of bruton's tyrosine kinase
MA42471A (fr) Compositions comprenant des souches bactériennes
MA47440B1 (fr) Sulfonylurées, composés apparentés, et leur utilisation
MA40283A (fr) Aptamères spécifiques du récepteur tlr-4 et leurs utilisations
MA48939B1 (fr) Compositions comprenant des souches bactériennes
MX2021001175A (es) Deposicion de hidratante mejorada en liquidos de limpieza que contienen polimeros anionicos modificados hidrofobicamente o no hidrofobicamente.
MA53086B1 (fr) Thiophènecarboxamides substitués et analogues comme agents antibactériens
BR112022002142A2 (pt) Anticorpos anti-bdca-2
MA38369B1 (fr) Peptides et compositions pour le traitement d'une lesion de l'articulation
WO2019075456A3 (en) Methods and substances for prevention and treatment of neurodegenerative diseases
MA49373B1 (fr) Compositions comprenant des souches bactériennes
WO2022125606A3 (en) Peptide therapeutics for treating alzheimer's disease and related conditions
FR3084255B1 (fr) Souche de streptococcus thermophilus cnrz160 pour le traitement et la prevention de l'inflammation intestinale et des desordres associes, chez un individu
WO2023114847A3 (en) Compositions and methods for treating disease
FR3087338B1 (fr) Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
EA202190546A1 (ru) Способы лечения инфекций с применением бактерий
EA202192488A1 (ru) Антитела против tsg-6 и их применения
EP4268822A3 (en) Compositions for treating vascular ehlers danlos syndrome
EA202092472A1 (ru) Высокомолекулярная гиалуроновая кислота для лечения и предупреждения тяжелого заболевания глазной поверхности
WO2017042577A8 (en) Novel therapy

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200424

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8